5-Azacytidine mediated reactivation of silenced transgenes in potato (Solanum tuberosum) at the whole plant level

Plant Cell Reports
Dimitrij TyčLukas Fischer

Abstract

Transient 5-azacytidine treatment of leaf explants from potato plants with transcriptionally silenced transgenes allows de novo regeneration of plants with restored transgene expression at the whole plant level. Transgenes introduced into plant genomes frequently become silenced either at the transcriptional or the posttranscriptional level. Transcriptional silencing is usually associated with DNA methylation in the promoter region. Treatments with inhibitors of maintenance DNA methylation were previously shown to allow reactivation of transcriptionally silenced transgenes in single cells or tissues, but not at the whole plant level. Here we analyzed the effect of DNA methylation inhibitor 5-azacytidine (AzaC) on the expression of two silenced reporter genes encoding green fluorescent protein (GFP) and neomycin phosphotransferase (NPTII) in potato plants. Whereas no obvious reactivation was observed in AzaC-treated stem cuttings, transient treatment of leaf segments with 10 μM AzaC and subsequent de novo regeneration of shoots on the selective medium with kanamycin resulted in the production of whole plants with clearly reactivated expression of previously silenced transgenes. Reactivation of nptII expression was accompanied by...Continue Reading

References

Oct 1, 1992·Plant Molecular Biology·N J KilbyI J Furner
Jun 25, 1981·Nucleic Acids Research·P A Jones, S M Taylor
Nov 1, 1981·Journal of Pharmaceutical Sciences·K T LinG E Rivard
Mar 7, 1996·Molecular & General Genetics : MGG·B JanousekB Vyskot
Sep 22, 2000·Plant Molecular Biology·M W MuskensJ M Kooter
Aug 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Werner AufsatzMarjori Matzke
Mar 6, 2003·Neuroscience Letters·Christian RamakersAntoon F M Moorman
Apr 5, 2003·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·C SallaudE Guiderdoni
Dec 21, 2004·Current Opinion in Oncology·Manel Esteller
May 3, 2005·TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik·M A FieldesJ C L Brown
Sep 29, 2005·Journal of Experimental Botany·Nathalie NicotDanièle Evers
Jul 4, 2007·The Plant Journal : for Cell and Molecular Biology·Sang-Ic KimStanton B Gelvin
Mar 5, 2008·The Plant Journal : for Cell and Molecular Biology·Jana Lunerová-BedrichováAles Kovarík
Sep 9, 2008·Current Opinion in Plant Biology·Daniel Zilberman
Sep 13, 2008·BMC Bioinformatics·Eyal GruntmanRavi Sachidanandam
Oct 2, 2008·The Plant Journal : for Cell and Molecular Biology·Tuncay BaubecOrtrun Mittelsten Scheid
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael T McCabePaula M Vertino
Jul 2, 2009·Molecular Genetics and Genomics : MGG·Scott J Nicholson, Vibha Srivastava
Sep 8, 2009·Nature·Marie MirouzeOlivier Mathieu
Apr 17, 2010·Science·Assaf ZemachDaniel Zilberman
Oct 27, 2011·Annals of Botany·Lenka DvorákováLukas Fischer
Apr 20, 2012·Plant & Cell Physiology·Chang-Ho EunKazuo Tsugane
Oct 17, 2012·PLoS Genetics·Devin Coleman-Derr, Daniel Zilberman
Jan 16, 2014·Current Opinion in Plant Biology·Concepcion M DiezBrandon S Gaut
Sep 26, 2015·Plant Cell Reports·Dunja Leljak-LevanićSnježana Mihaljević
Mar 24, 2016·Cell Biochemistry and Function·Amr Rafat Elhamamsy
Oct 1, 2002·Functional Plant Biology : FPB·Chris A HelliwellPeter M Waterhouse

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
phosphotransferase
PCR

Software Mentioned

Lucia
LinRegPCR
MS Excel
LightCycler 480
Zoner Photo Studio

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.